OVER DEZE AFLEVERING
Host: Matt Birnholz, MD
Guest: Donald Kohn, MD
Guest: Donald Kohn, MD
Third-generation lentiviral vectors were developed to improve upon safety measures and mitigate the risks of toxicity and replication that are typically associated with first- and second-generation therapies. These advancements may help enhance the functionality and utility of third-generation lentiviral vectors in various gene therapy applications. Learn more about the development, efficacy, and safety of third-generation lentiviral vectors with Dr. Matt Birnholz and Dr. Donald Kohn, Distinguished Professor at the University of California, Los Angeles.
This non-certified educational series is produced and controlled by ReachMD, and is intended for healthcare professionals only.
Engels
Verenigde Staten
IN DEZE AFLEVERING
TRANSCRIPTIE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OUDE AFLEVERINGEN ZOEKEN
Zoek naar eerdere afleveringen van Clinician's Roundtable.
ANDERE AFLEVERINGEN IN DEZE PODCAST
Guest: Anjay Rastogi, MD, PhD
Managing IgA nephropathy (IgAN) is becoming increasingly complex. In this episode, Dr. Anjay Rastogi explains why an expert opinion—not simply a second opinion—can help clinicians confirm diagnoses, optimize treatment decisions, and connect appropriate patie…
Host: Brian P. McDonough, MD, FAAFP
Guest: David A. Lieberman, MD
Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abn…
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Mallik Greene, PhD
Guest: Jordan Karlitz, MD
A study published in the Journal of the National Comprehensive Cancer Network examined follow-up colonoscopy rates after positive stool-based colorectal cancer screening tests, finding nota…
Host: Shelina Ramnarine, PhD
Guest: Samuel Ubanyionwu, PharmD, EMBA
Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, an…
Guest: Sayna Norouzi, MD
Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication t…
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van ReachMD, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
